Two Sigma Investments’s Scopus BioPharma Inc. Common Stock SCPS Stock Holding History

Two Sigma Investments’s Portfolio SCPS Stock Details SCPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-30,403	Closed	-$50K	–	4733
2021 Q4	$50K	Buy	+30,403	New	+$92.2K	﹤0.01%	4141
2021 Q3	–	Sell	-31,416	Closed	-$224K	–	4890
2021 Q2	$224K	Sell	31,416 -11,229	-26%	-$79.9K	﹤0.01%	3715
2021 Q1	$360K	Buy	+42,645	New	+$446K	﹤0.01%	3198

Other funds holding SCPS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MRCM

M&R Capital Management Summit, New Jersey $454M AUM 40.11% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Two Sigma Investments's SCPS Position: Q1 2022 in Review

Two Sigma Investments sold out of Scopus BioPharma Inc. Common Stock (SCPS) in Q1 2022, closing a stake of 30,403 shares — an estimated $50K sold.

Two Sigma Investments first reported a position in SCPS in Q1 2021 and held it in 3 quarters. The position peaked at $360K in Q1 2021. 19 funds tracked by Wall St. Rank hold SCPS as of Q1 2022.

Two Sigma Investments reported no remaining Scopus BioPharma Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Two Sigma Investments sold 30,403 Scopus BioPharma Inc. Common Stock shares in Q1 2022, an estimated $50K.
Two Sigma Investments first reported a position in Scopus BioPharma Inc. Common Stock in Q1 2021 and held it in 3 quarters.
Two Sigma Investments's Scopus BioPharma Inc. Common Stock position peaked at $360K in Q1 2021.
19 funds tracked by Wall St. Rank held Scopus BioPharma Inc. Common Stock as of Q1 2022.

Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.